(Q43850641)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Carmela Cursaro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Gian Luca Grazi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Antonia D'Errico

1 reference

ORCID Public Data File 2021

author name string

A Gramenzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Biselli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

L Di Giammarino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

E Jovine

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A D'Errico

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Galli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A Mazziotti

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A Cavallari

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Bernardi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

Digestive and Liver Disease

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

693-697

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

Liver transplantation in Italy: current status. Study Group on Liver Transplantation of the Italian Association for the Study of the Liver (A.I.S.F.).

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980047-5

7 January 2021

Recurrent hepatitis C after liver transplantation: clinical and therapeutical issues

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980047-5

7 January 2021

Rimantadine for treatment of hepatitis C infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980047-5

7 January 2021

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980047-5

7 January 2021

Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980047-5

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980047-5

7 January 2021

Posttransplantation prevention and treatment of recurrent hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980047-5

7 January 2021

Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980047-5

7 January 2021

Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980047-5

7 January 2021

10.1016/S1590-8658(01)80047-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11785716%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference